Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results

Johnson & Johnson will host a conference call for investors at 8:30 a.m. (Eastern Time) on Tuesday, October 16th, to review third-quarter results.  Joseph J. Wolk, Executive Vice President, Chief Financial Officer and Christopher DelOrefice, Vice President, Investor Relations will host the call.  The question and answer portion of the call will also include the following executives: Ashley McEvoy, Executive Vice President, Worldwide Chairman, Medical Devices; Jorge Mesquita, Executive Vice President, Worldwide Chairman, Consumer; and Jennifer Taubert, Executive Vice President, Worldwide Chairman, Pharmaceuticals. Investors and other interested parties can access the webcast/conference call in the following ways:

The webcast and presentation material are accessible at Johnson & Johnson’s website www.investor.jnj.com. A replay of the webcast will be available approximately three hours after the conference call concludes. By telephone: for both listen-only participants and those financial analysts who wish to take part in the question-and-answer portion of the call, the telephone dial-in number in the US is 877-869-3847. For participants outside the US, the dial-in number is 201-689-8261. A replay of the conference call will be available until approximately 12:00 a.m. on October 24, 2018. The replay dial-in number for US participants is 877-660-6853. For participants outside the US, the replay dial-in number is 201-612-7415. The replay conference ID number for all callers is 13683425. The press release will be available at approximately 6:45 a.m. (Eastern Time) the morning of the conference call. – Medical Buyer Bureau